Join MATTER partner Orthogonal for a discussion around the regulation of Software As a Medical Device (SaMD) in the U.S.
Join Orthogonal CEO and Founder Bernhard Kappe and Shriner and Associates Principal Quality and Regulatory Consultant Clay Anselmo as they discussed regulation around software as a medical device (SaMD) in the United States.
These industry experts discussed how regulation is essential for companies seeking approval of their SaMD by clinical and payer groups. They touched on the current status of SaMD regulation, understanding existing regulatory pathways, regulatory innovation at the FDA as well as development, launch and evolution of SaMDs under current regulatory frameworks and guidance.
This conversation was facilitated by Randy Horton, **Orthogonal **VP of Solutions and Partnerships.
Негізгі бет The Regulation of SaMD in the US
Пікірлер